Capstone Therapeutics Corp (CAPS)

May 16, 2025, 8:00 AM EDT - 17 days ago

Capstone Reaffirms $100M Revenue Target for 2025, Accelerates M&A Strategy with Flexible Growth Capital

Apr 9, 2025, 9:00 AM EDT - 7 weeks ago

Capstone Targets Growth in Southeast, Identifies Key Acquisition Candidates

Apr 1, 2025, 9:00 AM EDT - 2 months ago

Capstone Targets $100M Run Rate Increases Q4 Revenue and Executes Strategic Brand Expansion

Mar 20, 2025, 7:45 AM EDT - 2 months ago

Capstone Sees Minimal Effect from China Tariffs, Decrease in Container Prices Offsets Tariffs

Mar 18, 2025, 7:45 AM EDT - 2 months ago

Capstone Sees 30%+ Growth in Thin Brick Veneer, Rolls Out New Products at its Instone Business

Mar 5, 2025, 8:15 PM EST - 3 months ago

Capstone Holding Corp. Announces Pricing of Follow-On Public Offering and Uplisting of its Shares on Nasdaq Capital Market

Jan 4, 2025, 12:30 AM EST - 5 months ago

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

AERO CRGT FBGL FLOC INLF INR NNNN

Dec 9, 2024, 1:15 PM EST - 6 months ago

Capstone Holding Corp. Announces CEO Change

May 3, 2024, 12:15 PM EDT - 1 year ago

Capstone Holding Corp. Reinstates Tax Benefit Plan

Dec 29, 2023, 11:45 AM EST - 1 year ago

Capstone Holding Corp. Announces Change in Board of Directors

Nov 21, 2023, 5:55 PM EST - 1 year ago

Capstone Holding Corp. Announces Change of Equity Ownership in Diamond Products Holding, LLC

Aug 28, 2023, 12:00 PM EDT - 1 year ago

Capstone Holding Corp. Announces CFO Change

Mar 7, 2023, 2:45 PM EST - 2 years ago

Capstone Therapeutics Corp. Announces Results Of Annual Meeting

Mar 7, 2023, 2:45 PM EST - 2 years ago

Capstone Therapeutics Corp. Announces Results of Annual Meeting

Jun 21, 2022, 12:00 PM EDT - 3 years ago

Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC

Feb 25, 2022, 11:10 AM EST - 3 years ago

Capstone Therapeutics Corp. Announces Name Change to Capstone Holding Corp.

Dec 28, 2020, 1:50 PM EST - 4 years ago

Capstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC and Change in Control